Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study
dc.contributor.author | Bastard, M | |
dc.contributor.author | Sanchez-Padilla, E | |
dc.contributor.author | du Cros, P | |
dc.contributor.author | Khamraev, AK | |
dc.contributor.author | Parpieva, N | |
dc.contributor.author | Tillyashaykov, M | |
dc.contributor.author | Hayrapetyan, A | |
dc.contributor.author | Kimenye, K | |
dc.contributor.author | Khurkhumal, S | |
dc.contributor.author | Dlamini, T | |
dc.contributor.author | Perez, SF | |
dc.contributor.author | Telnov, A | |
dc.contributor.author | Hewison, C | |
dc.contributor.author | Varaine, F | |
dc.contributor.author | Bonnet, M | |
dc.date.accessioned | 2018-05-08T14:24:27Z | |
dc.date.available | 2018-05-08T14:24:27Z | |
dc.date.issued | 2018-03-08 | |
dc.date.submitted | 2018-05-03 | |
dc.identifier.citation | Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study. 2018, 13 (3):e0193491 PLoS ONE | en |
dc.identifier.issn | 1932-6203 | |
dc.identifier.pmid | 29518098 | |
dc.identifier.doi | 10.1371/journal.pone.0193491 | |
dc.identifier.uri | http://hdl.handle.net/10144/619119 | |
dc.description.abstract | The emergence of resistance to anti-tuberculosis (DR-TB) drugs and the HIV epidemic represent a serious threat for reducing the global burden of TB. Although data on HIV-negative DR-TB treatment outcomes are well published, few data on DR-TB outcomes among HIV co-infected people is available despite the great public health importance. | |
dc.language.iso | en | en |
dc.publisher | Public Library of Science | en |
dc.rights | Published by Public Library of Science, [url]http://www.plosone.org/[/url] Archived on this site by Open Access permission | en |
dc.title | Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study | en |
dc.identifier.journal | PloS ONE | en |
refterms.dateFOA | 2019-03-04T13:52:54Z | |
html.description.abstract | The emergence of resistance to anti-tuberculosis (DR-TB) drugs and the HIV epidemic represent a serious threat for reducing the global burden of TB. Although data on HIV-negative DR-TB treatment outcomes are well published, few data on DR-TB outcomes among HIV co-infected people is available despite the great public health importance. |